Last Updated: Jun 06, 12:00 AM·XSTU
Cognetivity Neurosciences Ltd 1UB.SG
Cognetivity Neurosciences Ltd. Stock Analysis 1UB.SG
Cognetivity Neurosciences Ltd. operates as a technology company. The company is headquartered in Vancouver, British Columbia. The company went IPO on 2018-03-19. The firm has developed a cognitive testing platform, the Integrated Cognitive Assessment (ICA), for use in medical and commercial environments and other neurological conditions. The Company’s CognICA uses artificial intelligence and machine learning technology to test the performance of large areas of the brain to help detect early signs of cognitive dysfunction. The company is also focused on developing the ICA for home use, for the remote monitoring of patient’s progress under treatment regimens and for general home healthcare check-ups. CognICA is available for clinical use in the United States, United Kingdom, Europe, Canada and the Middle East. Its subsidiaries include Cognetivity Ltd. and Cognetivity FZ-LLC.
Read More Cognetivity Neurosciences Ltd (1UB.SG) Chart
Key Statistics of Cognetivity Neurosciences Ltd (1UB.SG)
Key statistics in the stock market are essential financial indicators that measure a company's performance, valuation, profitability, and risk.
Today's Range
Today's Open
€0.00Volume
-P/E Ratio (TTM)
-Financial Metrics & Statements of Cognetivity Neurosciences Ltd (1UB.SG)
Super Investors Invested in Cognetivity Neurosciences Ltd (1UB.SG)
FAQ's for Cognetivity Neurosciences Ltd (1UB.SG)
- As of July 2026, Cognetivity Neurosciences Ltd 1UB.SG is classified as not covered according to Musaffa’s Shariah screening methodology. This classification is based on an assessment of the company’s business activities and financial ratios against Islamic investment guidelines.
- A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes Cognetivity Neurosciences Ltd using these criteria to determine its compliance status.
- Muslim investors may consider investing in Cognetivity Neurosciences Ltd if it meets Shariah compliance standards. Investors typically review the company’s business activities, debt levels, and non-permissible income before making a decision.
- Musaffa determines the Shariah status of Cognetivity Neurosciences Ltd by analyzing whether the company’s core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.
- The Shariah compliance status of Cognetivity Neurosciences Ltd may be updated periodically when new financial statements, earnings reports, or business activity information become available.
- Yes. A stock that is currently Shariah-compliant may become non-compliant if the company’s financial ratios exceed Shariah thresholds or its business activities change.
- You can check the latest Shariah compliance status of Cognetivity Neurosciences Ltd on Musaffa’s stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.
